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Available online 16 May 2013AbstractBackground: Paeonia officinalis, commonly known as European peony (family: Paeoniaceae) is native to south-eastern Europe and has been
introduced widely elsewhere (including Kashmir) as a garden plant. Roots of P. officinalis have been reported to possess abortifacient, anti-
hypertensive, and antiulcer activity. It has been used in traditional Unani, homeopathic, and Chinese systems of medicine for curing liver
disorders such as bladder stones and jaundice, besides being used in treating stomach ache, diarrhea, labor pains, nightmares, epilepsy, and
lunacy.
Purpose: The present study was undertaken to investigate the hepatoprotective potential of the 70% ethanolic extract of the roots of P. officinalis.
Methods: In the present study, the efficacy of a 70% ethanolic extract of the roots of P. officinalis was evaluated against carbon tetrachloride
(CCl4)-induced hepatic damage in rats. P. officinalis, at doses of 100 mg/kg and 200 mg/kg, was administered orally once daily for 14 days.
Results: CCl4 produced a significant increase in the serum levels of aspartate transaminase, alanine transaminase, alkaline phosphatase, and total
bilirubin in rats, while a decrease in total protein levels was observed. In rats that had received extracts of P. officinalis along with CCl4,
substantially elevated levels of aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), and total bilirubin were
lowered significantly in a dose-dependent manner, while total protein levels were elevated. Histopathology revealed regeneration of the liver in
extract-treated groups while silymarin-treated rats were almost normal.
Conclusion: The results of this study indicate that roots of P. officinalis possess hepatoprotective activity.
Copyright  2013, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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The liver is a vital organ of paramount importance because
it is involved in the maintenance of metabolic functions and
detoxification of exogenous and endogenous substances such
as xenobiotics, drugs, viral infection, and chronic alcoholism.
Liver diseases (also called hepatic diseases) have become a
global problem, which account for about 20,000 deaths every
year.1 Damage to liver is always associated with cellular ne-
crosis and an increase in the serum levels of many biochemical* Corresponding author. Department of Pharmaceutical Sciences, University
of Kashmir, Hazratbal, Srinagar 193201, Jammu and Kashmir, India.
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http://dx.doi.org/10.1016/j.jacme.2013.04.001markers such as aspartate transaminase (AST), alanine trans-
aminase (ALT), alkaline phosphatase (ALP), and bilirubin.2
Numerous medicinal plants and their formulations are used
for liver disorders in ethnomedical practices and traditional
systems of medicine in India.3 About 160 phytoconstituents
from 101 plants have been reported to possess hep-
atoprotective activity.4,5
The roots of P. officinalis (Ood Saleeb) have been used in
Unani, Ayurvedic, and homeopathic systems of medicine for
years.6 In Unani medicine, its roots are used as an ingredient in
many antioxidant preparations.6,7 InAyurvedicmedicine, root is
a part of medicinal preparations used for treating disease states
such as jaundice, dropsy, hepatitis, hepatomegaly, liver
dysfunction, cirrhosis, and sluggish liver.7 Roots are also used in
homeopathy for the treatment of liver problems.8,9 An aqueousMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
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activity; however, no scientific study has been conducted to
confirm the antihepatotoxic potential of its ethanolic extract.10
With this background, the present study was undertaken to
investigate the hepatoprotective potential of the 70% ethanolic
extract of the roots of P. officinalis against carbon tetrachloride
(CCl4)-induced hepatotoxicity in albino rats.
CCl4 is a widely used industrial chemical and a potent hep-
atotoxin. It induces hepatotoxicity by producing free radicals,
which in turn induce oxidative stress that causes lipid peroxi-
dation in liver tissues, leading to necrotic liver damage.11
2. Materials and methods2.1. Plant materialDried roots of P. officinalis were obtained from a local
Unani hospital in Kashmir, after proper identification and
authentication of plant material at the Centre for Biodiversity
& Taxonomy, University of Kashmir, Srinagar. A sample of
the plant material was deposited in the herbarium of the
Department of Taxonomy, University of Kashmir, under
voucher specimen number 1051/KASH for future reference.2.2. Preparation of extractAn alcoholic extract (70% v/v ethanol) of the roots of P.
officinalis was prepared following the standard method.12 The
roots were pulverized and subjected to extraction. The
powdered material (1 kg) was exhaustively extracted (3 cycles/
hour) with 70% ethanol in a Soxhlet apparatus (Borosil 3740-
extraction apparatus Borosil, Connaught Place, New Delhi,
India) by continuous hot extraction. The extract was evapo-
rated to dryness under reduced pressure and controlled tem-
perature conditions (40e50C) (yield 10%, w/w).2.3. Preliminary phytochemical screeningThe powdered plant material was subjected to preliminary
phytochemical screening. The standard qualitative and quan-
titative methods were used to test the presence of saponins,
tannins, alkaloids, flavonoids, anthraquinones, glycosides, and
reducing sugars.132.4. AnimalsAlbino rats of Wistar strain, both sexes, weighing
125e250 g, were procured from the animal house of the In-
dian Institute of Integrative Medicine (IIIM), Jammu. The
animals were kept in polypropylene cages (6 in each cage)
under standard laboratory conditions (12-hour light and
12-hour dark: day and night cycle), and had free access to a
commercial pelleted diet (Ashirwad Industries, Mohali,
Punjab, India) and tap water ad libitum. All studies were
performed in accordance with the guidelines for the care and
use of laboratory animals, as adopted and promulgated by the
Committee for the Purpose of Control and Supervision ofExperiments on Animals (CPCSEA), Institutional Animal
Ethical Committee, Department of Pharmaceutical Sciences,
India (Reg. No. IAEC/PHARM.S/CL/KU/2012). All the
chemicals used were of analytical grade from standard com-
panies, and double-distilled water was used always.2.5. Acute oral toxicity studyThe acute toxicity study was carried out in vivo in albino rats.
Solutionsof the dried extractswereprepared using2%gumacacia
in distilled water. The study was conducted as per the Organiza-
tion of Economic Cooperation andDevelopment (OECD/OCDE)
test guidelines on acute oral toxicity using a computer-guided
statistical program (AOT425statPgm, version 1.0, Developed by
Westat (Rockville, United States) for the U.S. Environmental
Protection Agency).14
P. officinalis roots have been reported to be toxic at higher
doses15; the main test of the up-and-down procedure was
conducted as per the guidelines, using the dose progressions of
175 mg/kg, 550 mg/kg, and 2000 mg/kg of the oral ethanolic
extract.2.6. CCl4-induced hepatotoxicityAnimals were divided into five groups, with six rats in each
group. Rats of the first group served as control animals and
received a single daily dose of gum acacia [1 mL of 2%, w/v,
per oral (p.o.) body weight (b.w.)].16 The second group
received only CCl4 [1 mL/kg b.w., intraperitoneal (i.p.), 1:1 v/
v mixture of CCl4 and olive oil].
17 Rats of the third group
received a silymarin suspension (100 mg/kg b.w., p.o.) along
with CCl4, while rats in the fourth and fifth groups received
orally 100 mg/kg b.w. and 200 mg/kg b.w. of ethanolic extracts
of P. officinalis in 2% gum acacia (w/v), respectively, along
with CCl4. The ethanolic extract was given daily to the
respective groups, while CCl4 was administered every 72
hours for 14 days.172.7. Assessment of hepatoprotective activityAfter 14 days of drug treatment, the rats were fasted
overnight. On the 15th day, they were anesthetized with diethyl
ether, and blood from each animal was collected, by retro-
orbital plexus puncture, in sterilized centrifuge tubes. Blood
samples were then allowed to coagulate at 30C for 45 mi-
nutes. Serum was separated by centrifugation at 2500 rpm at
30C for 15 minutes and subjected to biochemical in-
vestigations using standard test kits to assess liver function.
The following biochemical investigations were carried out in
serum: serum ALT,18 serum AST,19 serum ALP,20 total bili-
rubin,21 and total serum protein.22
After collecting the blood samples, animals from all groups
were sacrificed by cervical dislocation. Abdomen of each
animal was cut open to excise the liver. These livers were then
washed with normal saline and fixed in 10% neutral formalin
solution to be processed separately for histological
observation.
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routine hematoxylin and eosin stain for photomicroscopic
assessment. The initial examination was qualitative, with the
purpose of determining histopathological lesions in liver tissue.23
3. Statistical analysis
All the results were expressed as mean  standard error of
the mean (SEM). One-way analysis of variance (ANOVA) was
used for the statistical analysis of data. Student t test was used
for determining the significance. A p value <0.05 was
considered significant and p < 0.01 was taken to be highly
significant.
4. Results4.1. Preliminary phytochemical screeningPhytochemical screening revealed that the roots of P. offi-
cinalis contain alkaloids, tannins, saponins, glycosides, car-
bohydrates, flavonoids, terpenes, steroids, and proteins.4.2. Acute oral toxicityThe 70% ethanolic extract did not cause any mortality up to
a dose of 2000 mg/kg and was considered safe.4.3. Biochemical estimationsThe effect of P. officinalis on serum marker enzymes is
presented in Table 1. In the present study, CCl4 given at a dose
of 1 mL/kg b.w. (along with olive oil 1:1) produced a signif-
icant rise in serum AST, ALT, ALP, and bilirubin levels and a
significant fall in the total protein levels, indicating consider-
able hepatocellular injury. Administration of the 70% etha-
nolic extract of P. officinalis at doses of 100 mg/kg and
200 mg/kg produced a significant reduction in the AST, ALT,Table 1
Effect of the 70% ethanolic extract of the Paeonia officinalis roots on biochemica
Treatment AST (IU/L) ALT (IU/L
Normal control (2% gum acacia,
1 mL/kg p.o.)
88.75  11.14 269.14  12.46
Toxic control (CCl4; 1 mL/kg i.p.) 379.2  26.13** 768.60  42.15**
CCl4 þ silymarin (100 mg/kg p.o.) 97.88  5.83*** 284.33  5.40***
CCl4 þ 100 mg/kg p.o. of ethanolic
extract
216.61  31.96**, **** 345.29  14.32**
CCl4 þ 200 mg/kg p.o. of ethanolic
extract
173.37  15.39**, **** 307.72  10.87**
Data are expressed as the mean  SEM; n ¼ 6.
*p < 0.05, significant differences from the normal control group.
**p < 0.01, significant differences from the normal control group.
***p < 0.05, significant differences from the CCl4 group.
****p < 0.01, significant differences from the CCl4 group.
ALP ¼ alkaline phosphatase; ALT ¼ alanine transaminase; AST ¼ aspartate transa
units; p.o. ¼ per oral; SEM ¼ standard error of the mean; TB ¼ total bilirubin; TALP, and total bilirubin levels and a significant rise in the total
protein levels in a dose-dependent manner.4.4. Histopathological observationsA histopathological examination of the liver slides of
normal control rats showed normal parenchyma and normal
portal tract (Fig. 1A). Liver of the rats administered with only
CCl4 (toxic control) showed inflammation of the portal triad,
fatty change and necrosis of the periportal zone, necrosis,
sinusoidal dilatation, inflammation, hemorrhage, and vascular
congestion of the centrizonal area (Fig. 1B). The livers of rats
treated with CCl4 along with silymarin (100 mg/kg/day)
showed almost normal-appearing liver parenchyma, with
occasional necrotic foci in the periportal area (Fig. 1C).
Animals that had received CCl4 along with an ethanolic
extract of P. officinalis (100 mg/kg/day) showed mild sinu-
soidal dilatation, inflammatory cell infiltration, and hemor-
rhage around the bile duct across the entire liver tissue region
(Fig. 1D). The livers from animals administered with CCl4
along with an ethanolic extract of P. officinalis (200 mg/kg/
day) showed mild inflammatory cell infiltration across the
entire liver tissue (Fig. 1E).
5. Discussion
From the results of the acute oral toxicity study of the
ethanolic extract, it can be concluded that the LD50 of the drug
is greater than 2000 mg/kg b.w, that is, an ethanolic extract of
the root powder of P. officinalis is safe for administration up to
a dose of 2000 mg/kg b.w.
CCl4 at a dose of 1 mL/kg b.w. (i.p.) every 72 hours for 14
days has been reported to produce hepatotoxicity. Therefore,
in the present study, CCl4 was administered at a dose of 1 mL/
kg b.w. (along with olive oil 1:1) on Day 1 of the study and
then every 72 hours during the 14-day study period.
The results of this experiment reveal that the 70% ethanolic
extract of the roots of P. officinalis has a definitive anti-
hepatotoxic effect ( p < 0.01) against the deleterious effects ofl parameters against CCl4-induced hepatotoxicity in rats.
) ALP (IU/L) TB TP
122.64  9.78 1.48  0.11 9.97  1.61
345.49  22.02** 7.85  0.64** 5.21  0.56**
141.39  13.08*** 1.83  0.22*** 15.27  1.01*, ***
, **** 233.41  13.18**, *** 4.66  0.18**, **** 12.08  0.87*, ****
, **** 167.24  9.23**, **** 2.52  0.24**, **** 14.14  0.76*, ****
minase; CCl4 ¼ carbon tetrachloride; i.p. ¼ intraperitoneal; IU ¼ international
P ¼ total protein.
Fig. 1. Histopathology of liver tissues. (A) Liver from a control group rat: showing a normal portal tract and a large portal vein. (B) Liver from an animal treated
with CCl4 only: showing sinusoidal dilatation and a focus of necrosis with inflammatory cell infiltration and hemorrhage. (C) Liver from an animal treated with
CCl4 and silymarin (100 mg/kg/day): showing normal liver parenchyma and occasional necrotic foci in the periportal area. (D) Liver from a rat treated with CCl4
and an ethanolic extract of Paeonia officinalis (100 mg/kg/day): showing inflammatory cell infiltration and hemorrhage around a bile duct across the entire liver.
(E) Liver from rats treated with CCl4 and an ethanolic extract of P. officinalis (200 mg/kg/day): showing inflammatory cell infiltration across the entire liver tissue.
BD ¼ bile duct; CCl4 ¼ carbon tetrachloride; CV ¼ central vein, PT ¼ portal triad; PV ¼ portal vein.
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(100 mg/kg and 200 mg/kg) of the 70% ethanolic extract
attenuated the increase in the levels of AST, ALT, ALP, and
total bilirubin effectively; increased the total protein levels
produced by CCl4 significantly; and caused subsequent re-
covery toward normalization, comparable to the levels in
control and the standard group animals. The hepatoprotective
effect was more pronounced at the dose of 200 mg/kg/day than
at 100 mg/kg/day.
Histopathological studies also confirm the hepatoprotective
role of the 70% ethanolic extract of the P. officinalis roots in
antagonizing the deleterious effects of CCl4 on the histology
of liver. While CCl4-treated rats showed extensive histological
changes, the animals treated concurrently with CCl4 and
the 70% ethanolic extract of P. officinalis at doses of100 mg/kg/day and 200 mg/kg/day showed only moderate to
mild changes. The dose of 200 mg/kg/day of the ethanolic
extract was found to be more effective than the dose of
100 mg/kg/day in protecting the liver against the hepatocel-
lular injury caused by CCl4.
Various other Paeonia species, such as Paeonia lactiflora24
and Paeonia radix,25 have been observed to possess anti-
hepatotoxic activity against CCl4-induced liver injury. It has
been established that the hepatoprotective activity of these
Paeonia species is due to the presence of glycosides in them.
Total glucosides of peony have been found to protect hepa-
tocytes from the oxidative damage induced by CCl4. Since we
have already reported that roots of P. officinalis also contain
glycosides, it can be assumed that the hepatoprotective activity
of P. officinalis roots is due to the antioxidant activity of its
49F. Ahmad, N. Tabassum / Journal of Acute Medicine 3 (2013) 45e49glycoside content; however, this needs to be verified experi-
mentally in future studies.
In the future, studies should be conducted on this drug to
verify whether its hepatoprotective activity is due to the total
glycoside content; we also need to study the effect of higher
doses of this medicinal herb on liver protection.
6. Conclusion
The results of this study strongly indicate the protective
effect of P. officinalis roots against acute liver injury in rats,
which may be attributed to its glycoside content.
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